Nothing Special   »   [go: up one dir, main page]

FR2828401B1 - COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR A MIMETIC COMPOUND OF IGF1, AND ASCORBIC ACID AND / OR AT LEAST ONE OF ITS DERIVATIVES - Google Patents

COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR A MIMETIC COMPOUND OF IGF1, AND ASCORBIC ACID AND / OR AT LEAST ONE OF ITS DERIVATIVES

Info

Publication number
FR2828401B1
FR2828401B1 FR0110753A FR0110753A FR2828401B1 FR 2828401 B1 FR2828401 B1 FR 2828401B1 FR 0110753 A FR0110753 A FR 0110753A FR 0110753 A FR0110753 A FR 0110753A FR 2828401 B1 FR2828401 B1 FR 2828401B1
Authority
FR
France
Prior art keywords
igf1
cosmetic
association
derivatives
ascorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0110753A
Other languages
French (fr)
Other versions
FR2828401A1 (en
Inventor
Lionel Breton
Chrystelle Liviero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0110753A priority Critical patent/FR2828401B1/en
Priority to PCT/FR2002/002850 priority patent/WO2003013464A1/en
Publication of FR2828401A1 publication Critical patent/FR2828401A1/en
Application granted granted Critical
Publication of FR2828401B1 publication Critical patent/FR2828401B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0110753A 2001-08-10 2001-08-10 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR A MIMETIC COMPOUND OF IGF1, AND ASCORBIC ACID AND / OR AT LEAST ONE OF ITS DERIVATIVES Expired - Fee Related FR2828401B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0110753A FR2828401B1 (en) 2001-08-10 2001-08-10 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR A MIMETIC COMPOUND OF IGF1, AND ASCORBIC ACID AND / OR AT LEAST ONE OF ITS DERIVATIVES
PCT/FR2002/002850 WO2003013464A1 (en) 2001-08-10 2002-08-09 Composition comprising an association between igf1 and the ascorbic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0110753A FR2828401B1 (en) 2001-08-10 2001-08-10 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR A MIMETIC COMPOUND OF IGF1, AND ASCORBIC ACID AND / OR AT LEAST ONE OF ITS DERIVATIVES

Publications (2)

Publication Number Publication Date
FR2828401A1 FR2828401A1 (en) 2003-02-14
FR2828401B1 true FR2828401B1 (en) 2003-11-07

Family

ID=8866489

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0110753A Expired - Fee Related FR2828401B1 (en) 2001-08-10 2001-08-10 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR A MIMETIC COMPOUND OF IGF1, AND ASCORBIC ACID AND / OR AT LEAST ONE OF ITS DERIVATIVES

Country Status (2)

Country Link
FR (1) FR2828401B1 (en)
WO (1) WO2003013464A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102013025813A2 (en) * 2013-10-04 2015-08-25 Sanofi Aventis Farmacêutica Ltda Composition for treatment of diabetic ulcers, process of preparation of the composition and its use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002610B (en) * 1991-01-02 1997-02-20 Johnson & Johnson Consumer Products Inc. Wound healing compositions containing fibroplast growth factor and ascorbic acid
EP0516901A1 (en) * 1991-06-06 1992-12-09 Richard L. Lindstrom Method and apparatus of a serumfree medical solution
DE4208552A1 (en) * 1992-03-17 1993-09-23 Liedtke Pharmed Gmbh TOPICAL MEDICINE FORMS WITH INSULIN
WO1994004184A2 (en) * 1992-08-12 1994-03-03 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US5762922A (en) * 1994-01-31 1998-06-09 Ludwig Institute For Cancer Research Antioxidants and intracellular gluthathione raising agents for therapeutic treatments
US6337320B1 (en) * 1996-10-11 2002-01-08 Thione International, Inc. Reparatives for ultraviolet radiation skin damage
IL142914A0 (en) * 1998-11-09 2002-04-21 Consorzio Per La Gestione Del Serum free medium for chondrocyte-like cells

Also Published As

Publication number Publication date
FR2828401A1 (en) 2003-02-14
WO2003013464A1 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
FR2825277B1 (en) COSMETIC AND / OR DERMATOLOGICAL AND / OR PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST ONE ENZIME 3, B-HSD IHNIBITOR COMPOUND
CA2312528A1 (en) Cosmetic toning compound containing at least one hydroxystilbene in association with ascorbic acid
FR2807322B1 (en) COMPOSITION, ESPECIALLY COSMETIC, COMPRISING ASCORBIC ACID IN ASSOCIATION WITH AN ASCORBIC ACID DERIVATIVE
ATE225341T1 (en) PACLITAXELE SUBSTITUTED BY THIO IN 6 POSITION
FR2746316B1 (en) NEW COSMETOLOGICAL OR DERMATOLOGICAL COMPOSITIONS
EP0880963A3 (en) Association of a retionoid with a polyamino-polymer
FR2784294B1 (en) COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING AT LEAST ONE WALL EXTRACT, AT LEAST ONE SCUTELLAR EXTRACT AND AT LEAST ONE SALICYLIC ACID DERIVATIVE
CA2163706A1 (en) Amino Acid Derivatives of Paclitaxel
CA2255229A1 (en) Use of cinnamic acid, or of its derivatives, as a firming agent in a cosmetic composition
FR2773711B1 (en) COMPOSITION COMPRISING HONEY, AT LEAST ONE ESSENTIAL OIL AND / OR AT LEAST ONE DERIVATIVE OF ESSENTIAL OIL
FR2826263B1 (en) COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN AN ELASTIC INHIBITOR COMPOUND OF THE N-ACYLAMINOAMIDE FAMILY AND AT LEAST ONE ANTI-INFLAMMATORY COMPOUND
ATE363267T1 (en) AGENTS FOR IMPROVING SKIN TEXTURE
BR9804027A (en) New beta-keto esters
FR2695318B1 (en) TOPICAL COMPOSITION FOR THE REJUVENATION OF THE SKIN.
DE69711649D1 (en) P1, P4-DITHIO-P2, P3-MONOCHLOROMETHYLENE 5 ', 5' '' - DIADENOSINE-P1, P4-TETRAPHOSPHATE USED AS ANTI-THROMBOSE AGENT
MXPA03008111A (en) Topical composition comprising an aldehyde or ketone-based cosmetic bonding agent.
DE69802777D1 (en) 2,4-bis (4-amidino) phenylfurans as anti-pneumocystis carinii agents
BR9506389B1 (en) silicon, and dietary, cosmetic and therapeutic composition.
EP0820766A3 (en) New topical compositions containing very low doses of melatonin or derivatives thereof and their use in cosmetics
FR2828401B1 (en) COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR A MIMETIC COMPOUND OF IGF1, AND ASCORBIC ACID AND / OR AT LEAST ONE OF ITS DERIVATIVES
FR2788689B1 (en) COSMETIC COMPOSITION COMPRISING AT LEAST ONE WAX AND AT LEAST ONE CERAMID-LIKE COMPOUND AND METHODS
FR2778560B1 (en) USE OF CINNAMIC ACID OR AT LEAST ONE OF ITS DERIVATIVES IN A COMPOSITION FOR PROMOTING DEQUAMATION OF THE SKIN, AND COMPOSITION COMPRISING SAME
FR2772610B1 (en) USE OF CINNAMIC ACID OR AT LEAST ONE OF ITS DERIVATIVES IN A COSMETIC COMPOSITION
FR2828400B1 (en) COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR AN IGF1 MIMETIC COMPOUND, AND AT LEAST ONE RETINOIDE AND / OR AT LEAST ONE RETINOID DERIVATIVE
FR2828402B1 (en) COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A COMBINATION OF IGF1 AND / OR AN IGF1 MIMETIC COMPOUND AND AT LEAST ONE ISOFLAVONOID

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060428